埃博拉病毒疫苗。
A Vaccine against Ebola Virus.
机构信息
La Jolla Institute for Immunology, La Jolla, CA, USA.
出版信息
Cell. 2020 Apr 2;181(1):6. doi: 10.1016/j.cell.2020.03.011.
PMID:32243796
Abstract
Ervebo is the first licensed vaccine for prevention of Ebola virus disease. The vaccine, originally developed by the Public Health Agency of Canada, is delivered in a single 1 mL dose and has been delivered to >200,000 people in an ongoing 2018-2020 outbreak of disease. To view this Bench to Bedside, open or download the PDF.
摘要
Ervebo 是首个获得许可用于预防埃博拉病毒病的疫苗。该疫苗最初由加拿大公共卫生局开发，采用单次 1 毫升剂量给药，已在 2018-2020 年持续爆发的疾病中向超过 20 万人提供。要查看本从实验室到病床的转化，请打开或下载 PDF。
Zotero 插件